About Us

Luye Pharma Group (02186.HK), a member of Luye Life Sciences Group, is an international pharmaceutical company dedicated to the R&D, manufacturing and sale of innovative medications.

First Subject Enrolled in Phase 1 Clinical Trial for Luye Pharma’s Investigational Antidepressant Targeting NET/DAT/GABAAR

News

Shanghai, August 3, 2025 -- Luye Pharma Group today announced that the first subject has been enrolled in a Phase 1 clinical trial in China for its LY03021, which was filed through China’s Class 1 pathway for innovative drugs. LY03021 is an ...

August 03,2025

Luye Pharma Launches Its Transdermal Patch Rotigotine Luye in the UK for the Treatment of Parkinson’s Disease and Restless Legs Syndrome

Shanghai, April 10, 2025 – Luye Pharma Group announced the recent launch of its rotigotine transdermal patch, Rotigotine Luye, in the UK. This product is indicated for the treatment of the signs and symptoms of early-stage and advanced ...

April 10,2025

Read More

Investors

Employee Stories

Upholding the philosophy of “Employee Development”,
Luye Pharma regards employees as the most valuable resources of the company